Niki BioSolutions NIKI
NASDAQ NIKI
$4.90 +0.16 (+3.38%)
At close: Sep 30, 2026 · 4:00 PM EDT

Niki BioSolutions (NIKI) Convertible Debt (2017 - 2025)

Updated

Niki BioSolutions (NIKI) recorded Convertible Debt of $614,182 in FY2024.

Analysis

Niki BioSolutions (NIKI) Convertible Debt (2017 - 2025) Analysis & Trends

Starting with FY2017, Niki BioSolutions' Convertible Debt history includes 5 years.

  • Annual Convertible Debt has a five-year compound annual growth rate of -29.0% (FY2019 to FY2024).
  • The FY2024 figure is the lowest annual Convertible Debt since FY2017.
  • Per Business Quant data, NIKI's Convertible Debt was $3.06 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Niki BioSolutions 2.67 Mn 2.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2025 1.12 Mn
May 31, 2024 614,182.00
Dec 31, 2023 3.06 Mn
Dec 31, 2019 3.39 Mn
Dec 31, 2018 3.03 Mn
Dec 31, 2017 480,000.00
API Access

Niki BioSolutions Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=NIKI&period=max&api_key=YOUR_API_KEY